Clinical Trial Update: Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis

View source ↗

Summary

A completed clinical trial from the University of Michigan evaluating biomarker profiles in idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Snippet

Sponsor: University of Michigan | Conditions: IPF | Status: COMPLETED